3-O-Benzyl-4-(HydroxyMethyl)-1,2-O-Isopropylidene-Alfa-D-Ribofurano←se

63593-03-3

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprαise that is market-oriented and realizes industrial developmeΩnt through R&D innovation and technology transformation.

key word:

Pharmaceutical technology

Category:

Intermediate

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to bu€ild a large health industry finance platform company integrating pharmac eutical, intelligent medical, bio pharmaceutical R&D, industrial product≤ion and sales.

The chemical reactions involved in the existing products include Foucault reaction, nitration∑ reaction, sulfonation reaction, hydrogenation reaction, fluorination reactionΩ, chlorination reaction, bromination reaction, diazotization reaction, format rφeaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor deve​loped by Merck. In October 2006, Sitagliptin phosphate Jan≠uvia was approved by FDA as the first DPP4 inhibitor for the tβreatment of type ⅱ diabetes mellitus. The characteristics of this drug  are that it can stimulate insulin secretion while reducing hunger πwithout causing weight gain. Hypoglycemia and edema will not occur, and it is suitable γfor diabetic patients with poor blood glucose control and frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical ente♠rprise that is market-oriented and realizes industrial development through R&D innovation and tec®hnology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen i↔s one of the most important products for the treatment of arthritis. It is well tolerated a→nd has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three αmajor leukotriene receptor antagonists. In clinical application, it has good therapeuti€c effect on atopic asthma and other types of bronchial asthma, and the market prospect is huge™. In the major category of asthma drugs, leukotriene receptor antagonists have the fastest gro®wing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pha÷rmaceutical enterprise that is market-oriented and realizes industrial development through R&D  innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FεDA for Alzheimer's disease in the United States. Its treatment reaches the target dose and ha↕s low toxic and side effects. It has been widely recognized by our medical community, and good to≈lerance is its biggest advantage. In October 1999, Donepez✘il was launched in China under the trade name "Ari≠cept", which is the main chemical drug against Alzheimer's‌ disease. At present, CFDA has approved a number of domest≈ic enterprises to produce donepezil preparations, the main dosage forms are tablets→, capsules, dispersive tablets, oral disintegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Ap₽ixaban (Eliquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor, was appro✔ved for use in the 27 EU member states. The world's first drug approved to prevent venous thromboem≤bolism (VTE) in adult patients undergoing elective hip or knee₹ replacement. From June 2019 to June 2020, the annual sales of apixaban products overseas r≠eached about $15.4 billion, with a year-on-year growth of neεarly 32%, and the API consumption reached about 23,960 kg, with£ a year-on-year growth of about 28%. Compared with its main competitor, Rivaroxaban, the drug's> annual overseas sales are about $4.5 billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is≈ market-oriented and realizes industrial development through R&D innovation Ωand technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by Genzyme. On December 29,∏ 2004, it was approved by FDA for the treatment of refractory or relapsed acute lymphoblastic le←ukemia (ALL) in children.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-o™riented and realizes industrial development through R&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other servic¥es, E-mail: 2880705932@qq.com

Copyright © 2022 Anhui Union Pharmaceuticals Technology Co., Ltd.